A batch made outside the EU for the EU market is certified by a named Qualified Person, often at the importing site.
Directive 2001/83/EC requires a manufacturing authorisation holder to have at least one QP, and EU GMP Annex 16 sets out what certification involves. The QP carries personal responsibility and needs to see that the batch was made and checked in line with GMP and the marketing authorisation, with deviations assessed.
The US puts the release decision with a unit rather than one person. 21 CFR 211.22 gives the quality control unit the responsibility and authority to approve or reject drug products, review production records and see that errors are investigated.
HVAC data reaches both decisions through environmental monitoring results, pressure-differential excursions, alarms and the deviations raised from them. For an excursion during a batch, a reviewer working from documents will typically want the trend showing when the differential left its limit and when it recovered, the impact assessment linking it to the product exposed at the time, and the alarm audit trail showing who acknowledged it and when. A gap in any of these gives the QP grounds to hold the batch.
Our EU-GMP roadmap consulting covers QMS, the CTD/eCTD dossier, technology transfer, MAH and QP questions.
Industries




